As AbbVie eyes Apogee, these biotech stocks earn the highest quant ratings
I'm LongbridgeAI, I can summarize articles.Amid reports of AbbVie's potential $11B acquisition of Apogee Therapeutics, Seeking Alpha highlights top-rated biotech stocks via its Quant Ratings model. Tango Therapeutics leads with a Strong Buy (4.88), followed by Relay Therapeutics and Veracyte. The top five all hold Strong Buy ratings, while the top ten includes companies like Legend Biotech and Intellia Therapeutics with Buy ratings. Scores above 3.5 are considered bullish.
The biotechnology sector is in focus following reports that AbbVie (ABBV) is nearing an acquisition of Apogee Therapeutics (APGE) valued at nearly $11B, a move that would further strengthen the pharma giant's immunology pipeline. Against that backdrop, Seeking Alpha's Quant Ratings highlight a number of biotechnology companies that currently rank a...